Brachyolmia-amelogenesis imperfecta syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2899OMIM:601216Q76.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Brachyolmia-amelogenesis imperfecta syndrome is an extremely rare genetic disorder characterized by the combination of brachyolmia (a group of skeletal dysplasias primarily affecting the spine with platyspondyly, or flattened vertebral bodies) and amelogenesis imperfecta (a defect in tooth enamel formation). The condition affects both the skeletal and dental systems. Patients typically present with short trunk and mild short stature due to vertebral abnormalities, along with teeth that have thin, pitted, or poorly mineralized enamel that may appear yellow-brown and be prone to rapid wear and breakage. The skeletal features include platyspondyly (flattened vertebral bodies) visible on radiographic imaging, which leads to a disproportionately short trunk. The dental manifestations involve defective enamel development affecting both primary and permanent teeth, resulting in increased dental sensitivity, susceptibility to caries, and cosmetic concerns. Other skeletal features may include mild limb shortening or irregularities of the long bone epiphyses. Treatment is symptomatic and supportive. Dental management is a key component of care and may include protective crowns, bonding, or other restorative dental procedures to preserve tooth structure and function. Orthopedic monitoring is recommended to assess spinal changes over time. Genetic counseling is advised for affected families. Due to the extreme rarity of this condition, there are no disease-specific therapies, and management relies on a multidisciplinary approach involving clinical geneticists, orthopedic specialists, and dental professionals.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Brachyolmia-amelogenesis imperfecta syndrome.

View clinical trials →

No actively recruiting trials found for Brachyolmia-amelogenesis imperfecta syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Brachyolmia-amelogenesis imperfecta syndrome community →

No specialists are currently listed for Brachyolmia-amelogenesis imperfecta syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Brachyolmia-amelogenesis imperfecta syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Brachyolmia-amelogenesis imperfecta syndromeForum →

No community posts yet. Be the first to share your experience with Brachyolmia-amelogenesis imperfecta syndrome.

Start the conversation →

Latest news about Brachyolmia-amelogenesis imperfecta syndrome

No recent news articles for Brachyolmia-amelogenesis imperfecta syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Brachyolmia-amelogenesis imperfecta syndrome

What is Brachyolmia-amelogenesis imperfecta syndrome?

Brachyolmia-amelogenesis imperfecta syndrome is an extremely rare genetic disorder characterized by the combination of brachyolmia (a group of skeletal dysplasias primarily affecting the spine with platyspondyly, or flattened vertebral bodies) and amelogenesis imperfecta (a defect in tooth enamel formation). The condition affects both the skeletal and dental systems. Patients typically present with short trunk and mild short stature due to vertebral abnormalities, along with teeth that have thin, pitted, or poorly mineralized enamel that may appear yellow-brown and be prone to rapid wear and b

How is Brachyolmia-amelogenesis imperfecta syndrome inherited?

Brachyolmia-amelogenesis imperfecta syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Brachyolmia-amelogenesis imperfecta syndrome typically begin?

Typical onset of Brachyolmia-amelogenesis imperfecta syndrome is childhood. Age of onset can vary across affected individuals.